UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin[S]

Journal of lipid research, 2014-10, Vol.55 (10), p.2103-2112

2014

Volltextzugriff (PDF)

The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE3Leiden.CETP mice

European heart journal, 2017-08, Vol.38 (32), p.2499-2507

2017

Volltextzugriff (PDF)

Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE3Leiden.CETP mice

Arteriosclerosis, thrombosis, and vascular biology, 2008-11, Vol.28 (11), p.2016-2022

2008

Volltextzugriff (PDF)

Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism

The Journal of clinical investigation, 2007-11, Vol.117 (11), p.3583-3592

2007

Volltextzugriff (PDF)

PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE[S]

Journal of lipid research, 2014-11, Vol.55 (11), p.2370-2379

2014

Volltextzugriff (PDF)

Anacetrapib reduces (V)LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9[S]

Journal of lipid research, 2015-11, Vol.56 (11), p.2085-2093

2015

Volltextzugriff (PDF)

Torcetrapib Does Not Reduce Atherosclerosis Beyond Atorvastatin and Induces More Proinflammatory Lesions Than Atorvastatin

Circulation (New York, N.Y.), 2008-05, Vol.117 (19), p.2515-2522

2008

Volltextzugriff (PDF)

Niacin Reduces Atherosclerosis Development in APOE3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol

PloS one, 2013-06, Vol.8 (6), p.e66467

2013

Volltextzugriff (PDF)

Negative pressure ventilation: a special application of expiratory ventilation assistance

Intensive care medicine experimental, 2019-05, Vol.7 (1), p.22-2, Article 22

2019

Volltextzugriff (PDF)

Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE3-Leiden.CETP mice

The Journal of nutritional biochemistry, 2013-08, Vol.24 (8), p.1423-1430

2013

Volltextzugriff (PDF)

Flow-controlled ventilation - a new and promising method of ventilation presented with a review of the literature

Anaesthesiology intensive therapy : official publication of the Polish Society of Anaesthesiology and Intensive Therapy, 2022-01, Vol.54 (1), p.62-70

2022

Volltextzugriff (PDF)

Bexarotene Induces Dyslipidemia by Increased Very Low-Density Lipoprotein Production and Cholesteryl Ester Transfer Protein-Mediated Reduction of High-Density Lipoprotein

Endocrinology (Philadelphia), 2009-05, Vol.150 (5), p.2368-2375

2009

Volltextzugriff (PDF)

PET imaging of disease progression and treatment effects in the experimental autoimmune encephalomyelitis rat model

Journal of Nuclear Medicine, 2014-08, Vol.55 (8), p.1330-1335

2014

Volltextzugriff (PDF)

Niacin reduces plasma CETP levels by diminishing liver macrophage content in CETP transgenic mice

Biochemical pharmacology, 2012-09, Vol.84 (6), p.821-829

2012

Volltextzugriff (PDF)

Icosabutate Exerts Beneficial Effects Upon Insulin Sensitivity, Hepatic Inflammation, Lipotoxicity, and Fibrosis in Mice

Hepatology communications, 2020-02, Vol.4 (2), p.193-207

2020

Volltextzugriff (PDF)

Fenofibrate Increases Very Low Density Lipoprotein Triglyceride Production Despite Reducing Plasma Triglyceride Levels in APOE3-Leiden.CETP Mice

The Journal of biological chemistry, 2010-08, Vol.285 (33), p.25168-25175

2010

Volltextzugriff (PDF)

Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin

European heart journal, 2015-01, Vol.36 (1), p.39-50

2015

Volltextzugriff (PDF)

Mouse models for atherosclerosis and pharmaceutical modifiers

Arteriosclerosis, thrombosis, and vascular biology, 2007-08, Vol.27 (8), p.1706-1721

2007

Volltextzugriff (PDF)

Validation of Interventional Fiber Optic Spectroscopy With MR Spectroscopy, MAS-NMR Spectroscopy, High-Performance Thin-Layer Chromatography, and Histopathology for Accurate Hepatic Fat Quantification

Investigative radiology, 2012-04, Vol.47 (4), p.209-216

2012

Volltextzugriff (PDF)

Gender-dependent effects of high-fat lard diet on cardiac function in C57Bl/6J mice

Applied physiology, nutrition, and metabolism, 2012-04, Vol.37 (2), p.214-224

2012

Volltextzugriff (PDF)

Salsalate attenuates diet induced non‐alcoholic steatohepatitis in mice by decreasing lipogenic and inflammatory processes

British journal of pharmacology, 2015-11, Vol.172 (22), p.5293-5305

2015

Volltextzugriff (PDF)

Olmesartan and pravastatin additively reduce development of atherosclerosis in APOE3Leiden transgenic mice

Journal of hypertension, 2007-12, Vol.25 (12), p.2454-2462

2007

Volltextzugriff (PDF)

Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative

Liver international, 2020-11, Vol.40 (11), p.2860-2876

2020

Volltextzugriff (PDF)

Remote ischaemic preconditioning by brief hind limb ischaemia protects against renal ischaemia-reperfusion injury: the role of adenosine

Nephrology, dialysis, transplantation, 2011-10, Vol.26 (10), p.3108-3117

2011

Volltextzugriff (PDF)

Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE3Leiden.CETP transgenic mice with or without treatment with atorvastatin

Journal of hypertension, 2012-01, Vol.30 (1), p.107-116

2012

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

Science & Technology
(33)
Life Sciences & Biomedicine
(31)
Animals
(30)
Mice
(19)
Mice, Transgenic
(19)
Humans
(15)
Female
(14)
Male
(12)
Atherosclerosis
(11)
Apolipoprotein E3 - Genetics
(7)
Biological And Medical Sciences
(7)
Cardiovascular System & Cardiology
(7)
Cholesterol Ester Transfer Proteins - Genetics
(7)
Cholesterol Ester Transfer Proteins - Metabolism
(7)
Lipids
(7)
Liver - Drug Effects
(7)
Liver - Metabolism
(7)
Biochemistry & Molecular Biology
(6)
Cholesterol
(6)
Medical Sciences
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin[S]

The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE3Leiden.CETP mice

Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE3Leiden.CETP mice

Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism

PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE[S]

Anacetrapib reduces (V)LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9[S]

Torcetrapib Does Not Reduce Atherosclerosis Beyond Atorvastatin and Induces More Proinflammatory Lesions Than Atorvastatin

Niacin Reduces Atherosclerosis Development in APOE3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol

Negative pressure ventilation: a special application of expiratory ventilation assistance

Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE3-Leiden.CETP mice

Flow-controlled ventilation - a new and promising method of ventilation presented with a review of the literature

Bexarotene Induces Dyslipidemia by Increased Very Low-Density Lipoprotein Production and Cholesteryl Ester Transfer Protein-Mediated Reduction of High-Density Lipoprotein

PET imaging of disease progression and treatment effects in the experimental autoimmune encephalomyelitis rat model

Niacin reduces plasma CETP levels by diminishing liver macrophage content in CETP transgenic mice

Icosabutate Exerts Beneficial Effects Upon Insulin Sensitivity, Hepatic Inflammation, Lipotoxicity, and Fibrosis in Mice

Fenofibrate Increases Very Low Density Lipoprotein Triglyceride Production Despite Reducing Plasma Triglyceride Levels in APOE3-Leiden.CETP Mice

Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin

Mouse models for atherosclerosis and pharmaceutical modifiers

Validation of Interventional Fiber Optic Spectroscopy With MR Spectroscopy, MAS-NMR Spectroscopy, High-Performance Thin-Layer Chromatography, and Histopathology for Accurate Hepatic Fat Quantification

Gender-dependent effects of high-fat lard diet on cardiac function in C57Bl/6J mice

Salsalate attenuates diet induced non‐alcoholic steatohepatitis in mice by decreasing lipogenic and inflammatory processes

Olmesartan and pravastatin additively reduce development of atherosclerosis in APOE3Leiden transgenic mice

Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative

Remote ischaemic preconditioning by brief hind limb ischaemia protects against renal ischaemia-reperfusion injury: the role of adenosine

Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE3Leiden.CETP transgenic mice with or without treatment with atorvastatin

Suchergebnisse filtern